Assessment of Intravenous Rate Control Response in Atrial Fibrillation Trial (AIRCRAFT)

Stopped The study was not IRB approved and there were anticipated challenges in recruiting participants.

Conditions

• Atrial Fibrillation

Interventions

• DRUG: Beta-blocker strategy
• DRUG: Calcium channel blocker strategy
• DRUG: Physician preference strategy

Sponsor

Boston University